Haemaccel Infusion is a sterile, isotonic intravenous solution formulated to restore and maintain electrolyte balance and plasma volume in patients experiencing hypovolemia or electrolyte depletion. Each 100 mL contains Calcium Chloride 0.070 gm, Potassium Chloride 0.038 gm, and Sodium Chloride 0.85 gm, providing essential electrolytes critical for cellular function and cardiovascular stability. Calcium Chloride supports myocardial contractility and neuromuscular transmission, Potassium Chloride is vital for maintaining intracellular potassium levels and normal cardiac rhythm, while Sodium Chloride aids in fluid balance and osmotic equilibrium. Haemaccel Infusion is indicated for use in conditions such as dehydration, electrolyte imbalances, shock, and during surgical procedures requiring volume expansion. It should be administered intravenously under strict aseptic conditions, with dosage tailored to the patient’s clinical status and electrolyte requirements. Caution is advised in patients with hyperkalemia, hypercalcemia, renal impairment, or cardiac disorders. Monitoring of serum electrolytes, fluid status, and cardiac function is recommended during therapy to prevent potential complications such as hyperkalemia, hypercalcemia, or fluid overload. Haemaccel Infusion is a valuable therapeutic agent in the management of electrolyte disturbances and hypovolemia, contributing to the stabilization of hemodynamic parameters and overall patient recovery.